<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">zdor</journal-id><journal-title-group><journal-title xml:lang="ru">Проблемы здоровья и экологии</journal-title><trans-title-group xml:lang="en"><trans-title>Health and Ecology Issues</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2220-0967</issn><issn pub-type="epub">2708-6011</issn><publisher><publisher-name>Gomel State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.51523/2708-6011.2026-23-1-06</article-id><article-id custom-type="elpub" pub-id-type="custom">zdor-2935</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>Эффективность комбинированной реперфузионной терапии у пациентов с инфарктом мозга</article-title><trans-title-group xml:lang="en"><trans-title>Effectiveness of combined reperfusion therapy in patients with cerebral infarction</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-5101-5409</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Скачков</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Skachkou</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Скачков Александр Васильевич, заведующий неврологическим отделением № 1 (для пациентов с острым нарушением мозгового кровообращения) </p><p>г. Гомель </p></bio><bio xml:lang="en"><p>Aliaksandr V. Skachkou, Head of the Neurology Department № 1 (for patients with acute cerebral circulation disorder) </p><p>Gomel </p></bio><email xlink:type="simple">skachkov75@tut.by</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-2581-5357</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шваева</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Shvayeva</surname><given-names>A. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шваева Анастасия Дмитриевна, врач-невролог неврологического отделения № 1 (для пациентов с острым нарушением мозгового кровообращения) </p><p>г. Гомель </p></bio><bio xml:lang="en"><p>Anastasiya D. Shvayeva, Neurologist at Neurology Department № 1 (for patients with acute cerebral circulation disorder) </p><p>Gomel </p></bio><email xlink:type="simple">ashvayeva@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1706-0144</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Галиновская</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Halinouskaya</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Галиновская Наталья Викторовна, д.м.н., профессор, декан факультета повышения квалификации и переподготовки </p><p>г. Гомель </p></bio><bio xml:lang="en"><p>Natallia V. Halinouskaya, Doctor of Medical Sciences, Professor, Dean of the Faculty of Advanced Training and Retraining</p><p>Gomel </p></bio><email xlink:type="simple">halinouskaya@gsmu.by</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Гомельская университетская клиника — областной госпиталь инвалидов Великой Отечественной войны</institution></aff><aff xml:lang="en"><institution>Gomel University Clinic – Regional Hospital for Veterans of the Great Patriotic War</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Гомельский государственный медицинский университет</institution></aff><aff xml:lang="en"><institution>Gomel State Medical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>16</day><month>04</month><year>2026</year></pub-date><volume>23</volume><issue>1</issue><fpage>51</fpage><lpage>57</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Скачков А.В., Шваева А.Д., Галиновская Н.В., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Скачков А.В., Шваева А.Д., Галиновская Н.В.</copyright-holder><copyright-holder xml:lang="en">Skachkou A.V., Shvayeva A.D., Halinouskaya N.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.gsmu.by/jour/article/view/2935">https://journal.gsmu.by/jour/article/view/2935</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования. Проанализировать эффективность комбинированной реперфузионной терапии (РТ) у пациентов с инфарктом мозга (ИМ) на основе данных реестра неврологического отделения № 1 учреждения здравоохранения «Гомельская университетская клиника — областной госпиталь инвалидов Великой Отечественной войны» (Университетская клиника) за 2024 г.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Проведен ретроспективный анализ 30 случаев ИМ у пациентов, пролеченных в Университетской клинике за 2024 г. Среди них было 12 женщин,18 мужчин, средний возраст — 69 [62; 74] лет. Всем пациентам выполнен соматический и неврологический осмотр, клинические анализы, проведена оценка функционального статуса, выполнена компьютерная томография, установлен подтип ИМ согласно TOAST. Перед проведением системной тромболитической терапии (ТЛТ) и по окончании РТ оценен балл по шкале National Institutes of Health Stroke Scale (NIHSS). У каждого пациента выявлены временные интервалы оказания помощи: время «от начала до двери», «от двери до иглы», «от двери до пункции». Восстановление кровотока оценивалось по шкале Thrombosis in Cerebral Infarction (TICI). Исходы лечения оценены в конце острого периода. Данные анализировали с применением пакета Statistica, 10.0., языка программирования R.</p></sec><sec><title>Результаты</title><p>Результаты. Возраст пациентов, которым была проведена РТ, составил: 75 [71,3; 83] лет у женщин и 64 [56; 69] года у мужчин, р &lt; 0,001. Преобладающим патогенетическим подтипом был: атеротромботический у мужчин — 90 %, р = 0,046; кардиоэмболический у женщин — 42 %, р = 0,017. Временные параметры реперфузии соответствовали национальным требованиям: 93 [65; 110] мин «от начала до двери»; 35 [25; 110] мин — «от двери до иглы»; 97,5 [82; 140] мин — «от двери до пункции». Временные интервалы не отличались у пациентов с различными исходами ИМ. Удовлетворительный процент реперфузии составил 68 % &gt; 2 баллов по шкале TICI, летальность после РТ — 16 %. На исход ИМ у пациентов после РТ оказывал влияние балл NIHSS при поступлении: OR = 1,54, 𝜒2 = 6,34, р = 0,012.</p></sec><sec><title>Заключение</title><p>Заключение. Выявлены удовлетворительные результаты применения РТ в условиях неврологического отделения № 1 учреждения здравоохранения «Гомельская университетская клиника — областной госпиталь инвалидов Великой Отечественной войны»: летальность была меньше, чем указано в ряде литературных источников (16 % против 19 %). Выявлены факторы, коррекция которых потенциально может улучшить исход ИМ.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective. To analyze effectiveness of combined reperfusion therapy (RT) in patients with cerebral infarction (CI) based on registry data of Neurology Department No. 1 of the Gomel University Clinic – Regional Hospital for Veterans of the Great Patriotic War over 2024.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. A retrospective analysis of 30 cases of CI in patients treated at the Gomel University Clinic over 2024 was conducted. 12 women and 18 men, average age is 69 [62; 74] years old were involved. All patients underwent a somatic and neurological examination, clinical tests, functional status assessment, computed tomography was performed, and IM subtype was determined according to the TOAST. The National Institutes of Health Stroke Scale (NIHSS) score was assessed before conducting systemic thrombolytic therapy and after RT. Time intervals for providing assistance were defined for each patient: “from onset to door”, “from door to needle”, “from door to puncture”. Blood flow recovery was assessed using the Thrombosis in Cerebral Infarction (TICI) scale. Treatment outcomes were assessed at the end of the acute period. The data were analyzed using STATISTICA 10.0, R language.</p></sec><sec><title>Results</title><p>Results. The age of patients underwent RT was: 75 [71.3; 83] years old in women and 64 [56; 69] years old in men, p&lt;0.001. The predominant pathogenetic subtype was atherothrombotic in men — 90%, p=0.046, cardioembolic in women — 42%, p=0.017. The time parameters of reperfusion complied with the national requirements: 93 [65; 110] minutes “from onset to door”; 35 [25; 110] minutes from door to needle; 97.5 [82; 140] minutes “from door to puncture”. Time intervals did not differ in patients with different CI outcomes. Satisfactory reperfusion percent was 68% &gt; 2 points on the TICI scale, mortality after RT was 16%. The outcome of CI after RT was influenced by NIHSS score on admission: OR=1.54, 𝜒2=6.34, p=0.012.</p></sec><sec><title>Conclusion</title><p>Conclusion. Satisfactory results of RT application within the Neurology Department No. 1 of the Gomel University Clinic – Regional Hospital for Veterans of the Great Patriotic War were identified, with mortality lower than the literature data (16% versus 19%). The factors, correction of which can potentially improve the outcome of CI, were identified.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>инфаркт мозга</kwd><kwd>реперфузионная терапия</kwd><kwd>механическая тромбэктомия</kwd><kwd>системный тромболизис</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cerebral infarction</kwd><kwd>reperfusion therapy</kwd><kwd>mechanical thrombectomy</kwd><kwd>systemic thrombolysis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">GBD 2016 Stroke Collaborators. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:439-458. DOI: https://doi.org/10.1016/S1474-4422(19)30034-1</mixed-citation><mixed-citation xml:lang="en">GBD 2016 Stroke Collaborators. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:439-458. DOI: https://doi.org/10.1016/S1474-4422(19)30034-1</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke. Stroke. 2019;50:e344-e418. DOI: https://doi.org/10.1161/STR.0000000000000211</mixed-citation><mixed-citation xml:lang="en">Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke. Stroke. 2019;50:e344-e418. DOI: https://doi.org/10.1161/STR.0000000000000211</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Xiong Y, Chen HS, Wang AM, Wang Y, Pan Y, Liu L, et al. Rationale and design of tenecteplase reperfusion therapy in acute ischaemic cerebrovascular events III (TRACE III): a randomised, phase III, open-label, controlled trial. Stroke Vasc Neurol. 2024;9:e002310. DOI: https://doi.org/10.1136/svn-2023-002310</mixed-citation><mixed-citation xml:lang="en">Xiong Y, Chen HS, Wang AM, Wang Y, Pan Y, Liu L, et al. Rationale and design of tenecteplase reperfusion therapy in acute ischaemic cerebrovascular events III (TRACE III): a randomised, phase III, open-label, controlled trial. Stroke Vasc Neurol. 2024;9:e002310. DOI: https://doi.org/10.1136/svn-2023-002310</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Fan S, Wang Y, Hao Y, Liu L. Reperfusion therapy for acute ischemic stroke: where we are and where to go. J Transl Intern Med. 2025;13:1-3. DOI: https://doi.org/10.1515/jtim-2025-0001</mixed-citation><mixed-citation xml:lang="en">Fan S, Wang Y, Hao Y, Liu L. Reperfusion therapy for acute ischemic stroke: where we are and where to go. J Transl Intern Med. 2025;13:1-3. DOI: https://doi.org/10.1515/jtim-2025-0001</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Fransen PS, Beumer D, Berkhemer OA, et al. MR CLEAN, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study protocol for a randomized controlled trial. Trials. 2014;15:343. DOI: https://doi.org/10.1186/1745-6215-15-343</mixed-citation><mixed-citation xml:lang="en">Fransen PS, Beumer D, Berkhemer OA, et al. MR CLEAN, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study protocol for a randomized controlled trial. Trials. 2014;15:343. DOI: https://doi.org/10.1186/1745-6215-15-343</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a metaanalysis of individual patient data from five randomised trials. Lancet. 2016;387:1723-1731. DOI: https://doi.org/10.1016/S0140-6736(16)00163-X</mixed-citation><mixed-citation xml:lang="en">Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a metaanalysis of individual patient data from five randomised trials. Lancet. 2016;387:1723-1731. DOI: https://doi.org/10.1016/S0140-6736(16)00163-X</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378:11-21. DOI: https://doi.org/10.1056/NEJMoa1706442</mixed-citation><mixed-citation xml:lang="en">Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378:11-21. DOI: https://doi.org/10.1056/NEJMoa1706442</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018;378:708-718. DOI: https://doi.org/10.1056/NEJMoa1713973</mixed-citation><mixed-citation xml:lang="en">Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018;378:708-718. DOI: https://doi.org/10.1056/NEJMoa1713973</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">MacKenzie IER, Moeini-Naghani I, Sigounas D, et al. Trends in endovascular mechanical thrombectomy in treatment of acute ischemic stroke in the United States. World Neurosurg. 2020;138:e839-e846.</mixed-citation><mixed-citation xml:lang="en">MacKenzie IER, Moeini-Naghani I, Sigounas D, et al. Trends in endovascular mechanical thrombectomy in treatment of acute ischemic stroke in the United States. World Neurosurg. 2020;138:e839-e846.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kim J, Easton D, Zhao H, et al. Global stroke statistics 2023: availability of reperfusion services around the world. Int J Stroke. 2023;19:259-269. DOI: https://doi.org/10.1177/1747493023121044</mixed-citation><mixed-citation xml:lang="en">Kim J, Easton D, Zhao H, et al. Global stroke statistics 2023: availability of reperfusion services around the world. Int J Stroke. 2023;19:259-269. DOI: https://doi.org/10.1177/1747493023121044</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Campbell BCV. Hyperacute ischemic stroke care— current treatment and future directions. Int J Stroke. 2024;19:755- 762. DOI: https://doi.org/10.1177/17474930241239119</mixed-citation><mixed-citation xml:lang="en">Campbell BCV. Hyperacute ischemic stroke care— current treatment and future directions. Int J Stroke. 2024;19:755- 762. DOI: https://doi.org/10.1177/17474930241239119</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Meretja A, Keshtkaran A, Saver JL, et al. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. JAMA. 2013;309:2480-2485. DOI: https://doi.org/10.1001/jama.2013.6959</mixed-citation><mixed-citation xml:lang="en">Meretja A, Keshtkaran A, Saver JL, et al. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. JAMA. 2013;309:2480-2485. DOI: https://doi.org/10.1001/jama.2013.6959</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Saver JL, Goyal M, van der Lugt A, et al. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA. 2016;316:1279-1288. DOI: https://doi.org/10.1001/jama.2016.13647</mixed-citation><mixed-citation xml:lang="en">Saver JL, Goyal M, van der Lugt A, et al. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA. 2016;316:1279-1288. DOI: https://doi.org/10.1001/jama.2016.13647</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Mujanovic A, Strbian D, Demeestere J, Marto JP, Puetz V, Nogueira RG, Abdalkader M, et al. Safety and clinical outcomes of endovascular therapy versus medical management in late presentation of large ischemic stroke. Eur Stroke J. 2024;9:908-919. DOI: https://doi.org/10.1177/23969873241249406</mixed-citation><mixed-citation xml:lang="en">Mujanovic A, Strbian D, Demeestere J, Marto JP, Puetz V, Nogueira RG, Abdalkader M, et al. Safety and clinical outcomes of endovascular therapy versus medical management in late presentation of large ischemic stroke. Eur Stroke J. 2024;9:908-919. DOI: https://doi.org/10.1177/23969873241249406</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
